Thanussuyah Alaguthurai

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz et al. · The Lancet Oncology · 2021 · 608 citations · Full text

Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients

Sultan Abdul-Jawad, Luca Baù, Thanussuyah Alaguthurai et al. · Cancer Cell · 2021 · 114 citations · Full text

Their Legacies, Viral Persistence, Viral Diagnostics +10

Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal Metastasis

Amanda Fitzpatrick, Marjan Iravani, Adam Mills et al. · Clinical Cancer Research · 2021 · 68 citations · Full text

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines

Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz et al. · 2021 · 60 citations · Full text

Immunology, Cancer Patients, Vaccine Hesitancy +19

Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer

Elizabeth Harvey-Jones, Maya Raghunandan, Luisa Robbez‐Masson et al. · Annals of Oncology · 2024 · 54 citations · Full text